May 11, 2017 11:02 am UTC| Business
Geneva, Switzerland and Boston, MA - May 11, 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise...
NeuroDerm Announces First Quarter 2017 Financial Results
May 11, 2017 11:01 am UTC| Business
REHOVOT, Israel, May 11, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced financial results...
NeuroDerm Announces First Quarter 2017 Financial Results
May 11, 2017 11:01 am UTC| Business
REHOVOT, Israel, May 11, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced financial results...
May 11, 2017 11:01 am UTC| Business
NEW YORK, May 11, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, announced it will present...
May 11, 2017 11:01 am UTC| Business
NEW YORK, May 11, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, announced it will present...
uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates
May 11, 2017 11:01 am UTC| Business
–Effective Transduction Achieved After Readministration of Gene Transfer – –Preclinical Data Presented Today at American Society of Gene Cell Therapy (ASGCT) Annual Meeting in Washington, D.C.– –Investor Analyst...
uniQure Announces Successful Readministration of Gene Therapy in Non-Human Primates
May 11, 2017 11:01 am UTC| Business
–Effective Transduction Achieved After Readministration of Gene Transfer – –Preclinical Data Presented Today at American Society of Gene Cell Therapy (ASGCT) Annual Meeting in Washington, D.C.– –Investor Analyst...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight